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Abstract
Introduction: 
Haemophilus influenza is strictly a human pathogen responsible for many diseases like 
community acquired pneumonia, meningitis, sinusitis, epiglottitis and otitis media. 
Haemophilus type b is the most common strain responsible for all the infections. Non 
type able strains are at emerging risk. Ampicillin resistance is being reported and is due 
to production of betalactamases. Ampicillin resistance is being reported and is  due to 
production of betalactamase, but rarely can also be due to aminoacid substitutions in the 
Penicillin binding proteins (PBP) which is known as BLNAR 
AIM: 
  To isolate and characterize Haemophilus influenzae as pathogen from purulent 
respiratory samples over a period of 15 months. 
Materials and Methods:   
All purulent respiratory samples were processed for isolation of Haemophilus influenzae. 
They were identified as H. influenzae based on its X&V factor requirement and 
Porphyrin synthesis test.  Serotyping of the isolates was done using ‘b’, ‘a’ and ‘f’ typing 
sera. Antibiotic susceptibility testing was done with reference to detection of Ampicillin 
resistance. Ampicillin resistance was characterized by phenotypic and genotypic 
methods. PCR was done for detection of TEM -1 which codes for betalactamases 
enzyme. 
 
 
 
Results: 
Out of 103 Haemophilus influenzae isolates, majority of them were isolated from elderly 
male patients (49%) and show higher incidence during the winter months .Due to the 
vaccination available against type b Haemophilus influenzae, Non type b Haemophilus 
influenzae shows higher risk (67%) when compared to type b (33%).  None of the cases 
of type b is seen in children below 5 years of age. Haemophilus influenzae shows higher 
sensitivity pattern to ceftriaxone (91%),Azithromycin  (96%)and Tetracycline (97%). 
There is no difference in the susceptibility to drugs between type b and Non type b 
isolates. Beta lactamase positive H. influenzae were seen in 15 isolates .Out of them, 13 
showed TEM-1 beta lactamase gene by PCR. 
KEYWORDS: satellitism, XV factor requirement, Porphyrin synthesis test, Fildes 
agar,TEM-1 
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INTRODUCTION:  
Haemophilus influenzae is a commensal in human respiratory tract, now considered as 
an important cause of community acquired pneumonia. Of the infections caused by 
Haemophilus influenzae, the commonly observed are pneumonia, Sinusitis, Otitis media, 
septicemia, meningitis, cellulitis, arthritis and   epiglottitis 1. They are related to as the typical 
bacterial pathogens causing community acquired pneumonia next to Streptococcus 
pneumoniae. 
Haemophilus influenza is a short Pleomorphic Gram negative coccobacillary rod, 
fastidious in nature. H.influenzae was identified as Pfeiffer’s bacillus in 1892 and renamed as 
bacillus influenza in 1918. In the 1930s, Haemophilus influenza was classified in two 
different categories the capsulated and the non-capsulated strains by Pittman. It is mainly 
recovered from the human respiratory tract and very rarely from other sites. The mode of 
spread of the infection is mainly airborne droplets2 . 
Among the 6 capsulated strains (a, b, c, d, e, f) type b remains the most common cause 
of invasive diseases 2. Type b H.influenzae colonize the respiratory tract of children at a rate 
of 2- 4% which showed substantial decrease after the advent of conjugate vaccine2. 
. 
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Nontypeable strains (Non capsulated) commonly colonize the upper respiratory tract at 
a rate of 30-40%. They account for 25-35% as of cause Otitis media in children less than 5 
years of age and exacerbations of chronic obstructive pulmonary disease   in adults.4   
Haemophilus influenzae is confirmed by performing satellitism, in which the colony 
grows near the streak of staphylococcus aureus. Haemophilus influenza is a fastidious 
organism which requires two important factors, factor x (hemin factor) and factor v 
(nictoniamide adenine nucleotide factor) for its growth. 4The most reliable method to detect 
the requirement of these factors is the porphyrin synthesis test identified by kilian et al.5 
For epidemiological purposes Haemophilus influenzae can be classified in to eight 
biotypes based on three biochemical tests indole, Ornithine and urease. Of these biotypes, 
type b falls mostly  in biotype I. Strains isolated from healthy nasopharynx and from 
respiratory sputum samples comes under biotypes II and biotypes III 6. 
Among the six serotypes designated as a to f, all have antigenically distinct capsular 
polysaccharides. The type b strains have polyribitol phosphate capsule which is the important 
virulent factor. The capsulated strains can be identified by their seroagglutination with the 
specific antiserum. Type b alone is potentially vaccine preventable 7.  
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H.influenzae is sensitive to cold temperature and lyophilisation remains the ideal way 
for preservation.8  
      Infections caused by H.influenzae were initially being treated with cell wall active 
agents like Ampicillin and Chloramphenicol. Now the favored regimen is ceftriaxone, 
cefotaxime, tetracycline and Azithromycin. Some strains produce beta-lactamase enzyme 
TEM-1 which shows resistance to Ampicillin. By the year 1972 Haemophilus influenzae 
begin to show resistance to Ampicillin and the resistance started to spread rapidly because of 
production of beta lactamase enzyme .Both phenotypic and genotypic methods were used to 
detect Ampicillin resistance 9 
My study aim is to isolate, characterize the Haemophilus influenzae in a simplified 
manner and also to study the drug sensitivity and resistance patterns among the isolates 
obtained. 
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REVIEW OF LITERATURE: 
 Haemophilus influenza is known to cause infections like community acquired 
pneumonia, meningitis, sinusitis, acute otitis media and epiglottits. Rarely Haemophilus 
influenza also causes conjunctivitis and genital tract infections. Among the capsulated strains, 
type b is the most common cause of all these diseases. However the advent of vaccines has 
reduced the incidence of infections caused by type b. Non type b and other non-capsulated 
strains of Haemophilus are showing emerging trends 1. 
 Haemophilus influenza is Gram negative, Pleomorphic bacteria. In sputum samples it 
appears as clusters of coccobacillary forms whereas in CSF samples long, filamentous forms 
are seen. They are facultative anaerobic, nonmotile, nonsporing and most are capsulated. 
Haemophilus influenza requires two factors for its growth: factor X and factor V.  
 Factor X is the hemin factor and factor V is the nicotinamide adenine dinucleotide 
factor.Most of the species show catalase and oxidase reaction positive. Haemophlius genus 
consists of a total of 15 species among which Haemophilus influenza, Haemophilus 
aegypticus, Haemophilus haemolyticus alone requires both XV for its growth 2. 
 
HISTORY9, 10: 
        Historical perspective of discoveries regarding the Haemophilus influenza highlights 
that it was Pfeiffer in 1892 identified this genus in the sputum of the patients suffering from 
respiratory tract infections. As time passed on, Winslow in 1917 named the species which 
cause these diseases such as community acquired pneumonia, meningitis, acute otitis media 
as Haemophilus influenza. Before the discovery of Haemophilus influenza, Koch identified a 
species called Haemophilus aegypticus, which caused conjunctivitis in Egypt in 1933. 
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 Zeimann in 1967 restricted the genus Haemophilus to Gram negative rods or 
coccobacilli which requires factors X and V for its growth.9The G+C content of DNA is 37-
44 mol%. After the advent of the DNA-DNA hybridization technique and 16s RNA sequence 
comparison, the popularity of X and V has reduced 10. Among the different strains of 
Haemophilus species, based on multilocus sequence analysis Haemophilus aphrophilus and 
Haemophilus paraaphrophilus are classified in to Aggregatibacter aphrophilus and 
Aggregatibacter paraaphrophilus.Both hemin dependent and hemin independent 
A.aphrophilus isolates are also identified.  
Taxonomy 11: 
 Haemophilus comes under the family Pasteurellaceae which also includes other genera 
such as Pasteurella, Actinobacillus, and Lonipinella. These genera are again grouped under 
the order Pasteurellales in the gamma division of the Proteobacteria.   
Domain Bacteria 
Kingdom Eubacteria 
Phylum Proteobacteria 
Class  Gammobacteria 
Order Pasteurellales 
Family Pasteurellaceae 
Genus Haemophilus 
Species Influenza 
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SPECIES IN THE GENUS: 
 The genus Haemophilus consists of 15 species among which nine causes disease in 
humans and others in animals as per the Bergeys Manual of Determinative Bacteriology. 9                            
HUMAN SPECIES X V XV ANIMAL SPECIES( V factor ) 
H.influenza + + + H.parasuis(swine) 
H. aegypticus + + + H.paragallinarum(poultry) 
H.haemolyticus + + + H.paracuniculus(rabbits) 
H.parahemolyticus - + - H.haemoglobinophilus(dogs) 
H.aphrophilus + - - H.felis(cats) 
H.paraaphrophilus - + -  
H.paraaphrophaemolyticus - + -  
H.segnis - + -  
H.ducreyi + - -  
H. parainfluenzae - + -  
 
 Three species, namely, H.putoriorum, H.citreus, H.piscum alone do not require X and 
V factors. They need ATP for its growth9. In 1931, Pittman categorized the capsular serotypes 
of Haemophilus influenza as a, b, c, d, e, f   out of which type b is important as it causes the 
invasive diseases. 
             In 1984, DNA-DNA hybridization has limited the studies to certain genus 
H.influenzae, H.aegypticus, H.segnis, H.aphrophilus, H.paraaprophilus10. Ribotyping studies 
suggest that genus Haemophilus contain the above species. In 1988, Brenner identified 
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aegypticus as the subgroup of H.influenzae and it causes the Brazilian purpuric fever-severe 
conjunctivitis in paediatric age group. But in 2002, Kilian et al disproved as there is no 
genetic evidence for this.  
             Certain studies found that H.aphrophilus, so named because of its need for carbon 
dioxide for its growth, is an apparent ‘X factor dependent’ only on primary isolation and loses 
it on repeated subculture. DNA-DNA hybridization techniques a show that H.aphrophilus and 
H.paraaphrophilus are similar but major difference is   H.aphrophilus is X requiring whereas 
H.paraaphrophilus is V requiring 10. 
           In 1963 Turk, identified that the carriage rate of capsulated H.influenzae among five 
years of age group was around 2-4%. Other encapsulated strains 1-2% and non-capsulated 
strains are about 50-80%12. In 1964, additional species Haemophilus pleuropneumoniae was 
identified to cause infections such as fatal pneumonia like picture in swine. The specific 
feature of this species of Haemophilus along with H.parainfluenzae is that it possesses all the 
enzymes needed for heme synthesis and is porphyrin synthesis positive 5. 
CELL MORPHOLOGY13: 
  Haemophilus influenza is a small, slender, thin filamentous Pleomorphic cocco 
bacillary rod, irregularly stained, of size 0.3um-0.5um*0.5-1.0um with rounded ends.  
   Cultural Characteristics: 
          Good recovery of Haemophilus influenza in the laboratories depends on the proper 
collection, transport and use of appropriate media for isolation because of its fastidious 
nature. If the sample is cerebrospinal fluid, care should be taken that it is not refrigerated as 
the Haemophilus influenza dies off at extreme temperatures13, 10. 
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Medium used for isolation of Haemophilus influenzae: 
Blood agar10, 14: 
 
  On blood agar they form low, translucent, convex, pinpoint colonies around the 
staphylococcus which provides the factor V for its growth. The colonies are bigger in size 
near the Staphylococcus providing V factor and as it goes away the colonies decrease in size. 
This is the satellite phenomenon. 
   Studies suggest that "Plain rabbit blood-agar” prepared by adding 5% fresh rabbit 
blood to sterilized Trypticase Soy Agar serves as a better media for isolation. This medium is 
used in microbiology laboratories for detection of Haemophilus in respiratory specimens14.    
Colonies of H.aphrophilus and H.paraaphrophilus may pit the agar leading to 
misidentification with Eikenella corrodens. 
 Chocolate agar15: 
 
          Chocolate agar was prepared by heating nutrient agar base with 5 per cent sheep blood 
at 75-80o C for 15 minutes in a water bath. Studies suggest that supplementation of isovitaleX 
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to that of the chocolate agar enriched the growth of Haemophilus influenzae15. Haemophilus 
influenza shows a shiny, tiny colony which smells like wetfur11.Capsulated strains show 
small, mucoid, translucent colonies. Chocolate agar is good in identifying the fastidious 
organisms such as Haemophilus, Neisseria but it cannot differentiate H.hemolyticus and 
parahemolyticus from H.influenzae. 
 A study shows the comparison of the growth of Haemophilus influenzae in enriched 
chocolate agar, chocolate agar with vancomycin and chocolate agar with vancomycin, 
clindamycin and bacitracin and suggests that the isolation of Haemophilus is about 6%, 
28.5%, 59.9%. Hence chocolate agar with all the three antibiotics seems to be a better 
isolation medium for this pathogen from the contaminated upper respiratory tract flora16.  
       Haemophilus isolation medium 17: 
              This is a commercially available media that contains beef heart infusion, peptone, 
yeast extract and 5%defibrinated sheep blood containing X and V factors. Adding up of 
Bacitracin 300microgram/ml makes the medium more selective 11. 
            A study includes the comparison of different media for isolation, in which 
Gonococcal agar base with 1% yeast autolysate and 5% sheep blood yields a large easily 
recognizable colonies.    
 Levinthals agar 18:       
             On levinthals agar colonies show iridescence under transmitted light because of grid 
like arrangement of the bacteria. H.paragallinarum also shows iridescence on transmitted 
light. 
             Colonies of H.parainfluenzae are smooth, wrinkled 1-2 mm in diameter.  Literature 
studies on different media such as RPMI medium-based tissue culture media facilitate the 
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metabolic and genetic studies on Haemophilus influenza .The disadvantage of these media 
was that they did not support the growth of many non type able strains of Haemophilus 
influenzae18 
 Fildes agar 6, 19: 
            Chocolate agar or brain heart infusion agar with 5-10% fildes enrichment shows better 
isolation of Haemophilus. The supplement contains sodium chloride, Hydrochloric acid; 
defibrinated sheep blood pepsin, sodium hydroxide and chloroform. This yellow medium 
supports growth of Haemophilus species and other pathogens such as clostridium tetani 6. 
       Studies showed that Trypticase soy agar with 5% Fildes enrichment also serves as a good 
medium for primary isolation of Haemophilus influenzae 11. 
Other media:  
        Five beta lactamase positive and negative strains of Haemophilus influenzae was 
isolated and its  growth characteristics were observed in three different medias such as  
Mueller-Hinton broth - agar, brain heart infusion broth - agar, and tryptic soy broth - agar, 
and they are  supplemented with  (0.2% hemin-0.1% IsoVitaleX, 1% hemin-1% IsoVitaleX, 
2% sheep blood, 10% Fildes enrichment, 5% horse erythrocytes, 5% Fildes enrichment, 1% 
supplement B, and 2% hemoglobin-1% IsoVitaleX) 19.Comparitive analysis suggests that 
Muller Hinton broth,brain heart infusion broth and the trypticase soy. broth supplemented 
with 5% fildes enrichment showed the maximum growth of more than 108Cfu/ml rather than 
10% fildes supplement19. 
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 Factor X&V requirements: 
 
Factor x:  
             Hemin is an enzyme in respiration. Haemophilus influenzae requires heme to supply 
both iron and porphyrin to the bacterium. Haemophilus influenzae also has ferrochetalase 
enzyme as the source for iron 20. Since the hemolysin is not produced by the bacterium it 
cannot acquire its iron from the hemolysis of red blood cells. 
Various sources of hemin are heme-hemopexin, heme-albumin, and hemoglobin-haptoglobin 
complexes 21.While growing in the anaerobic condition the requirement of X factor decreases 
22.  This can be identified by supplying these factors in a Muller Hinton media. Growth can be 
seen around the Xfactor. Some Haemophilus strains require hemin itself since they lack 
ferrochetalase enzyme 20. H.aphrophilus loses its requirement to these factors following 
subculture 11. 
Factor v:  
            This is the second factor which is present in many tissues of plants and animals, 
synthesized by many bacteria except H.influenzae. It is a thermo labile vitamin, hence the 
name V factor 23. In the bacterial cell growth, this factor is involved in oxidation-reduction 
process. Nictoniamide (NAD+) acts as a coenzyme 24, 25.  This factor V is not readily available 
as it is largely intracellular. It is heat labile, destroyed at 1200C in few minutes. Certain 
bacteria such as Staphylococcus aureus and some fungi produce this factor V in excess and 
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release them in to the medium .Haemophilus influenza utilizes these released factors for its 
growth. 
Other dependent factors 26:  
  In addition to hemin and NAD factors, certain Haemophilus species requires purine, 
cystiene, pantothenic acid, thiamine, uracil and cysteine for its growth.   H.paragallinarum 
requires serum and sodium chloride, though it is not a halophilic 27. 
Satellitism test4, 10: 
 
            Studies suggest that H.influenzae grows as a shiny colony around the bacteria 
synthesizing the factor V like Staphylococci, Yeast and some fungus. The size of the colony 
decreases as it goes away from the factor V. This phenomenon is called satellitism and it 
helps in detecting these organisms in mixed cultures as well as serves as a presumptive test 
for genus level identification. X factor dependent Haemophilus may also grow as satellite 
colonies because hemin and hematin are released from lysed red blood cells by the action of 
hemolysin released by staphylococci.  
Literature studies compared five different studies such as satellitism, porphyrin synthesis test, 
acid production from sucrose, ONPG and indole production to differentiate Haemophilus 
influenzae from other species. Comparitive analysis suggest that 6%  satellitism test done 
with impregnation of X,V on to Colombia Agar misidentified  Haemophilus influenzae 
strains as Haemophilus parainfluenzae. Porphyrin synthesis test seems to be better in 
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identifying the X factor requirement. Haemophilus influenzae shows negative with acid 
production from sucrose while H.parainfluenzae shows positive results and this test is also 
comparatively good4. 
Porphyrin  synthesis test 28, 29: 
 
The ability to synthesize porphobilinogen and porphyrins from ALA (Aminolevulinic acid) is 
the basis of porphyrin test, which was first described by Biberstein.  
 
Enzymes required: 
1. Porphobilinogen synthetase 2. Uroporphyrinogen I synthetase 3. Uroporphyrinogen 
decarboxylase   4. Coporphyrinogen oxidase  5. Ferrochetalase 
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Hemin-dependent strains of H.influenzae are unable to convert ALA into protoporphyrin. 
This test is convenient and if properly performed is the best method   for demonstrating a 
hemin requirement. H.parainfluenzae serves as the positive control. 
      Literature studies by Killian suggest that the porphyrin test can be carried out using the 
substrate which contains 0.03352 of ALA hydrochloride,0.01972 of MgSo4.7H2O IN 100ML 
OF 0.1 Sorensen phosphate buffer,pH 6.9.Inoculate the organism and incubate it for 4 hours. 
To detect the porphyrin produced read under the woods lamp of longer wavelength. If red 
fluorescence is seen against white background then the organism doesn’t require Xfactor or 
hemin for its growth 28.  The other way is after inoculation for 4 hours add kovac’s reagent 
and then vortex well .Development of red aqueous layer indicates the lack of hemin 
requirement.    
 Literature studies compared five different studies such as satellitism, porphyrin 
synthesis test, acid production from sucrose, ONPG and indole production to differentiate 
Haemophilus influenzae from other species. Comparitive analysis suggest that 6%  satellitism 
test done with impregnation of X,V on to Colombia Agar misidentified  Haemophilus 
influenzae strains as Haemophilus parainfluenzae. Porphyrin synthesis test seems to be better 
in identifying the X factor requirement4. 
PHYSICAL REQUIREMENTS FOR GROWTH 30: 
 The optimum temperature for growth of Haemophilus is 35-37 o C. They are sensitive to heat 
and are inactivated at 55oC after a period of 30min. It grows better in aerobic than anaerobic 
conditions. However it grows better in the presence of 3-5% co 2.  
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VIRULENCE AND PATHOGENECITY: 
  Haemophilus influenza is mainly classified in to two major groups, namely, capsulated 
and non capsulated strains. Among the capsulated strains (a, b, c, d, e, f), type b is responsible 
for most of the infections, because of the presence of polyribosylribitol phosphate (PRP), a 
pentose sugar in its polysaccharide capsule. 
Capsular polysaccharide:  
         Production of the PRP Capsule is complex involving both capsule and non capsular 
genetic determinants. The cap B gene of H.influenzae is a duplication of two short identical 
segments of17-18 Kb segments. This capB gene contains a small bex A gene that is capable 
of bringing out the capsule to the cell surface13, 20. This duplicated Cap b gene is present in 
90% of H.influenzae type b whereas in the other capsulated strains this cap B gene appears as 
a single copy gene. Studies show that type b capsule deficient mutants can also show 50 fold 
increase in adherence to human epithelial cells and nearly a 300 fold increase in invasive 
Capillaries. The type b capsule of Haemophilus cross reacts with wide variety of bacteria 
including Streptococcus pneumoniae, Streptococcus pyogenes, Staphylococcus aureus, 
Staphylococcus epidermidis, Enterococcus faecium and Escherichia coli k100 31. Children 
less than 2 years do not have the anti-PRP antibodies and also Tcell independent nature of 
this age predisposes to many infections32 
          The conjugation of PRP to a protein carrier stimulates anti-PRP antibodies in young 
infants and this serves as basis of Hib vaccine 33.The PRP capsule also stimulates 
complement mediated bacteriolysis 34.  
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Other virulence factors 13,20  
   Fimbrial adhesions: 
          Type b strain and 30-40% of nontypeable strains also posses the fimbrial proteins. Type 
b strains also posses major proteins (Hif A) and two minor proteins (Hif D,E). The minor 
protein Hif E is present on the tip of the fimbriae and is responsible for haemagglutination 
and adherence to the host cell glycoproteins and glycolipids. These are other two proteins Hif 
C and Hif B which is responsible for fimbrial assembly and protection of fimbrial proteins 
during export from the cell. 
HMW1 AND HMW2 Adhesins: 
         These adhesin proteins are found on 70-80% of non typeable H.influenzae. Studies on 
non typeable H.influenzae mediated otitis media shows the presence of these HMW 
adhesions. 
  Hap Adhesin: 
 This is a non fimbrial adhesin protein present in all H.influenzae strains and has 
protease Activity. Studies show that intranasal inoculation of mice with this Hap adhesin 
inhibits nasopharyngeal Colonization. Other adhesion proteins are Hia, Hsf and opacity 
associated proteins. H.influenzae type b produce a bacteriocin called Haemocin which 
compete effectively with non typeable strains in nasopharyngeal colonization. 
lgA protease: 
  These proteases inactivate Human lg A1 and account for over 90% of lgA in 
oropharynx. Strains of Haemophilus aegypticus and H.influenzae biogroup aegypticus are 
more stably piliated 35.Piliated H.influenzae bind to erythrocytes, which contain the Anton 
(AnWj) antigen 36. 
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Lipooligosaccharide 22: 
 H.influenzae has an outer membrane LPS that contains Lipid A joined via             2-
keto-3 deoxy Octulosonic  acid to the core polysaccharide. Since it lacks the repeating 
terminal side chains ( O or somatic antigen ) ,LPS  is called as ‘LOS’. 
  Los Lipid A is responsible for Mitogenicity, pyrogenicity in rabbits, Platelet 
aggregation and Lethality in mouse endotoxemia model. 
 LOS phase variation occurs by changes in numbers of short four nucleotide sequences 
resulting In the codon –anticodon reading frame.LOS of many strains H.influenzae is 
sialylated and helps In opsonisation and phagocytosis 37.It serves as a potential antigen for 
vaccination of Non type able H.influenzae .Studies suggest that conjugate vaccines with 
tetanus toxoid reduced the incidence of Otitis Media due to nontypeable H.influenzae in the 
chin chilla model 38. 
Phase variation in LOS: 
                The shift in the codon anticodon reading frame is due to change in the numbers of 
short genomic four nucleotide sequence. This result in phase variations at the genetic level 
39.The sialylated LOS of H.influenzae is structurally and antigenically similar to human 
glycolated sphingolipids. 
                The complement system plays an important role in the pathogenesis of 
Haemophilus influenzae. LOS responds to change in the environmental conditions such as 
decreased oxygen level by increasing the expression of phosphorylcholine. Reason behind is 
H. influenzae possesses a redox-responsive regulatory system, the ArcAB two-component 
signaling system (TCS). Whenever the oxygen tension is low, ArcB senses the redox status of 
the quinone pool and autophosphorylates, leading to activation of ArcA by phosphoryl 
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transfer .This Arc A activates the enzymes involved in respiratory or fermentative 
metabolism. This Arc AB system plays an important role in the pathogenesis of nontypeable 
strains by controlling the expression of certain genes like lic2B and lic2C 40. 
OMPs: 
 These are 6 to 8 OMP in the cell wall outer membrane. It is one of the useful 
components in vaccine.P2 and P6 are the OMPs present in which P2 occupies 50% of the 
OMP. Antibodies against P2 protein are bactericidal and protective in animal models 41. By 
SDS – PAGE, nine OMP subtypes have been identified. These subtypes accounts for majority 
of infections worldwide. The epitopes of P2 is immunogenic and are directed against the non 
type able H.influenzae infections42.There is a variation in the expression of amino acid 
sequence in surface epitopes of P2 but those which is embedded inside the outer membrane 
are conserved43. P6 protein is about 1-5% on the surface of both type able and nontypeable 
strains44.Antibodies against P6 are bactericidal in the infant rat model and in the chinchilla 
model of otitis media 45.There is development of CMI and mucosal IgA  response in the 
infant rat by the intranasal immunization of  purified P6 vaccine46. P6 is highly conserved at 
the genetic level and warrants as a potential candidate in vaccine against nontypeable 
H.influenzae 47.  
CLASSIFICATION9, 11: 
  Haemophilus species identification can be done based on the acid and gas production 
from carbohydrates. Haemophilus influenzae shows catalase and oxidase test positive, nitrate 
reduced to nitrite and most strains of Haemophilus influenzae is urease positive which helps 
in biotype identification along with indole and ornithine. 
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Species catalase oxidase indole urease 
H.influenzae + + D D 
H.hemolyticus + + +/- + 
H.haemoglobinophilus + + + - 
H.ducreyi - + - - 
H. aphrophilus - - - - 
H.parainfluenzae +/- + D D 
H.parahaemolyticus +/- + - + 
 
Based on acid production: 
Species Glucose fructose galactose lactose mannose sucrose trehalose xylose 
H.influenzae + - + - - - - + 
H.hemolyticus + W + - - - - V 
H.haemoglobinophilus + W + - - - - V 
H.ducreyi - - - - - - - - 
H.aphrophilus + + + + - + + - 
H.parainfluenzae + + + - - + - - 
H.parahaemolyticus + + +/- - - + - - 
 
INFECTIONS12: 
 Capsulated strains of about 2-4% cause infection in young children and infection is 
commonly bacteremic resulting in Meningitis, epiglottitis, pneumonia, suppurative arthritis, 
osteitis, otitis media, cellulitis and pericarditis. 
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Non-capsulated strains of about 50-80% cause exacerbations of chronic bronchitis, otitis 
media, and conjunctivitis and paranasal sinusitis in adults and it is rarely bacteraemic.  
  Meningitis: 
 Meningitis is less common between two months of life to 4 years. In Britain, along 
with Neisseria, type b is mostly responsible for meningitis and accounts for 1 in 500 lives in 
the first 5 years of age 48. Even in USA, the infection rate is 1 in 500. Among Alaskan 
Eskimos the population risk is 1 in 50 but it is not due to special virulence of the type b 
strains or to any special susceptibility of Eskimo children 49.   It is because of greater 
exposure of the children to the bacteria before they developed immunity.   
 Clinically H.influenzae type b meningitis is similar to meningococcal meningitis. It is 
usually preceeded by viral upper respiratory tract infection and otitis media. The symptoms 
include fever, malaise and vomiting. Nuchal rigidity is usually absent. Complications include 
brain abscess 50.   
  Pneumonia 10, 12: 
         Pneumonia is usually lobar or segmental and the picture is similar to pneumonia caused 
by pneumococcal and even in its radiological appearance. Most commonly this bacterium is 
identified from respiratory samples. Clinical manifestations include cough, sputum, and 
pleuritic pain. Bacteraemic pneumonia is seen in elderly patients. 
Otitis media10:       
About one third of Nontypeable strains of Haemophilus commonly cause otitis media. 
It is associated with pain and fullness in ears, usually bilateral, bulging tympanic membrane. 
Swabs from the drainage of ear canal can be taken for cultures, otherwise aspiration should be 
done.   
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Bacteraemia 51, 52: 
       Bacteraemic infections caused by H.influenzae are usually not either localized or severe 
enough to hospitalize. Four cases had been identified in which trauma led to bacteraemic 
infection. They were 
1. Child crushed her hand in the door developed type b suppurative arthritis. 
2. Foreign body aspirated and its removal led to type b epiglottitis 
3. H/O fall led to type b meningitis 
4. Chronic bronchitis  
 Animal models were used to demonstrate the spread of bacteraemic infections of type 
b by using infant rat models. The bacteria was  introduced through the nasal mucosa and 
Haemophilus influenzae starts spreading from the nasal mucosa ,enters the circulation and 
finally led to meningitis rather than causing meningitis through cribriform plate12. 
OTHER INFECTIONS12: 
 Conjunctivitis: 
                     It was Koch in 1883 who first described an organism which is classified under 
the genus Haemophilus. It is called as Koch-weeks bacillus or Haemophilus aegypticus. Still 
there is confusion whether it is a separate species or a biogroup of H.influenzae 53. In Britain, 
these conjunctivitis cases occur as sporadic cases and are mainly due to non capsulated strains 
54. 
Genital tract infections: 
              Colonization of healthy vagina with non capsulated Haemophilus is very rare. 
However it causes salpingitis and tubo-ovarian abscess. Infection is more common among 
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those who have intrauterine devices or any previous infection 55. Perinatal infections may 
occur and the presenting features include turbid foul-smelling amniotic fluid. 
 Haemophilus influenzae can also be found rarely in faeces 56. It may also be associated 
with the presence of calculi or any abnormality of the urinary tract 57 H.parainfluenzae and 
H.aphrophilus are more involved in endocarditis than H.influenzae. 
ANIMAL PATHOGENICITY: 
 An early study on animal pathogenecity suggests that the type b capsulated forms are 
highly pathogenic on injecting into rabbits58. The same result has been derived in studies 
conducted on mice 59 and chick embryos 60. 
  The situation was complicated in 1960 that other capsulated strains of types can also 
be virulent for mice and showed that 2 strains, one derived from type b and other from type d 
strain. Type d strain was highly virulent in mice. From this it was deduced that virulence 
depends on the somatic as well as capsular composition 61. 
              In 1981, several studies were conducted on 3 months old infant rat to study the 
pathogenecity of influenzae.  
The main findings are 62: 
 On IV inoculation of 105 organisms, other than type a or b, all other types disappeared 
rapidly. Type ‘a’ then slowly disappeared leaving behind type b. 
 On peritoneal inoculation even in low doses only the type b strain caused bacteraemia. 
 On intranasal inoculation, type b and type d capsulated strain of the same and the non 
capsulated strain were equally efficient in establishing colonization of nasopharynx but 
type b caused bacteraemia and meningitis. 
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      In 1981, experiments on infant rat of same breed suggest that both type b & type d 
strains can cause bacteraemia on intranasal inoculation but type b strains are more virulent 
when given subcutaneously. The difference arises because of variation in bacterial strains and 
the inoculation technique 63. 
                The final conclusion from the rat experiments suggests that capsulated Strains of 
Haemophilus influenza; particularly type b is mostly responsible for all pathogenic infections. 
The type b capsule has a special virulent factor PRP (Polyribitolribose phosphate, a pentose 
sugar) which is the major pathogen. 
Non-typeable strains of Haemophilus influenzae 64: 
 These strains are seen in the nasopharynx of the children and cause both localized and 
invasive infections also. Because of the advent of the type b vaccination, these nontypeable 
strains have taken over importance as it causes bacteraemia, meningitis and respiratory tract 
diseases.  
 Both the typeable and nontypeable strains originate from the common noncapsulated 
ancestor. The nontypeable strains carry number of adhesive factors like HMW1/HMW2 
proteins, Hia, Hap and pili that play a major role in virulence. 
EPIDEMIOLOGY6, 29:  
 Haemophilus constitute 10% of the normal bacterial flora of the upper respiratory 
tract. The species H.parainfluenzae accounts for three-fourth of the oral cavity but is absent in 
nasal cavity. Non capsulated strains of H.influenzae constitute less than 2% of the total 
bacterial flora in the pharynx and the nasal cavity of the healthy children. 
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  As age increases, colonization of H.influenzae decreases but in contrast, patients with 
chronic obstructive disease often persistently colonize single or multiple clones of non 
capsulated H.influenzae. 
 H.influenzae infections often show seasonal variations and it is found to be most 
common in winter months .Crowding is one of the important factor in the transmission of the 
disease. The advent of vaccines especially against type b had shown dramatic decrease in the 
infection rate. 
MODE OF TRANSMISSION6, 29: 
 Haemophilus influenzae infections spread mainly as droplet infection. The portal of 
entry is usually through nasopharynx. The incubation period is 2-4 days. This infection is not 
highly contagious. Chances of secondary infections are more common among close contacts. 
Once the antibiotics are started, the chances of spread are very minimal. 
BIOTYPING 6: 
 For epidemiological purpose the Haemophilus species are grouped under eight 
different biotypes based on three tests Indole, ornithine and urease.  
TEST I II III IV V VI VII VIII 
INDOLE + + - - + - + - 
ORNITHINE  + - - + + + - - 
UREASE + + + + - - - - 
 It was in 1976, Kilian rekindled interest in the biochemical characterization of 
H.influenzae. He classified biotype 6 in which the species showed positive reaction to 
ornithine alone. A carriage study was carried out on the infants in Asaro valley of Eastern 
Highlands of Papua, New Guinea and a new H.influenzae strain 03635 was identified and all 
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three biochemical tests was done and it showed positivity to indole alone. This doesn’t fit in 
to any of the six biotypes as described by Kilian and so new biotype VII was designated to 
this strain 03635 65. 
  The rapid kits are available for the detection of the biotypes such as IDS RapID NH 
system, the NHI card, and the API NH strip and in the study by kilian, the API NH strip 
seems to be better than others in identifying the biotyoes.If there is much discrepancy in 
comparison of these three kits we go in for indole, ornithine, urease test66. The IDS RapID 
NH system was inferior to both of the other test systems because of false-positive ornithine 
decarboxylase results.                          
SEROTYPING:  
 Due to difference in the pathogenecity caused by capsulated or non capsulated strains, 
the need for detecting the type able strains gained importance. Of that, type b is the most 
common. Advent of vaccines against type b Haemophilus influenza had let down the 
infections caused by them. Studies show that still there is a rise in infections caused by 
Haemophilus influenzae is because of other capsulated strains and the nontypeable strains. A 
study on Alaskan residents  of age group around 10 years and above show a dramatic increase 
in infections from 0.5 to 1.1 per 1,00,000 years 68. 
  Among the serotypes Haemophilus influenza type f has gained importance now. The 
incidence of type f has increased from 0.5 cases per 1,000,000 populations on 1989 to 1.9 
cases per 1,000,000 populations in the year 1994.Out of that 72% of adults and 26% of 
children less than 5 years are commonly affected and the diseases caused are mainly the 
respiratory tract infections69.  
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 Like Haemophilus influenza type f, type a also gained importance. Study done in 
Salvador, Brazil says that after the advent of Hib vaccination the meningitis because of type b 
has decreased to 69% whereas the meningitis due to type a has increased 8-fold. Pulse field 
gel electrophoresis shows that type a belonged to 2 clonally related groups that were present 
before Hib vaccine emerged. Therefore, Hib immunization led to increased risk for H. 
influenzae type meningitis through selection of circulating H. influenzae type a clone. So 
monitoring of vaccination becomes essential70. 
  Recent study on Haemophilus influenza in a hospital in Spain, showed that a 5 month 
old non immunized infant with history of fever and lethargy and her lumbar puncture culture 
showed the presence of mucoid colonies of Haemophilus influenza and the isolate was sent to 
the national reference laboratory at the Istituto Superiore di Sanita` (Rome), where serotyping 
by slide agglutination and capsular genotyping by PCR were performed and was identified as 
type e of Haemophilus influenza. Similar picture was identified in 26 adults also. 
Haemophilus type e clinical scenario is not much similar to type b and it occurs as 
opportunistic pathogen 71. 
  Study on the epidemiology of serotype a in north American countries shows that 
among 88 typeable isolates, 42 (48%) were H. influenzae type a and it mainly affects the 
young children. Common clinical manifestations included meningitis, pneumonia, and septic 
arthritis. Overall annual incidence was 0.9 cases per 100,000 populations 72.  
OTHER TYPING METHODS67: 
 Sub typing based on OMP proteins, LPS or isoenzymes. 
 DNA based techniques like DNA fingerprinting, Ribotyping and Pulsefield gel 
electrophoresis. 
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 Multilocussequence typing-Best method where the seven housekeeping genes (adk, atp 
G, frd B, fuc K ,mdh, pgi, rec A. The advantage of this method is that it is 
electronically portable and easily comparable with other laboratories. 
ANTIBIOTIC SENSITIVITY PATTERN: 
  Most of the strains of Haemophilus influenzae respond to Ampicillin, Cephalosporins, 
Chloramphenicol, Sulfonamides, Tetracycline and the Macrolide antimicrobials. Ampicillin 
is used by most of the clinicians as the empirical treatment on suspicion of Haemophilus 
influenzae68.  
 By the year 1972 Haemophilus influenzae begin to show resistance to Ampicillin and 
the resistance started to spread rapidly because of production of beta lactamase enzyme75, 76. 
This beta lactamase enzyme was found to be very similar to R factor carrying type IIIa beta 
lactamase of E.coli and was named as TEM-177.The resistance spreads through two types of 
plasmids 30-megadalton and 3-megadalton,out of which 3-megadalton is common among 
many different species78,79.  
 Another beta lactamase enzyme is reported which is also plasmid mediated and cannot 
be detected by chromogenic cephalosporin method unlike TEM-1 80. Because of the plasmid 
mediated beta lactamase enzyme production many strains show resistance to Ampicillin.  
 Other methods of resistance are due to alteration in the target penicillin binding 
proteins. Literature studies says that Ampicillin resistance among Haemophilus influenzae is 
because of TEM-1 gene which is present in 90-95% of strains and 5-10% percent shows the 
presence of ROB-1 gene68.Another enzyme called VAT-1 gene can also lead to beta 
lactamase production but it is very rare11.   
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 One of the simple method to detect ampicillin resistance in laboratories is the usage of 
Haemophilus test medium (HTM),Muller Hinton-chocolate  agar and chocolate agar with 1% 
Fildes enrichment.HTM includes Mueller-Hinton medium with 15 micrograms of hematin 
per ml, 15 micrograms of NAD per ml, and 5 mg of yeast extract per ml as growth-promoting 
additives. A better result is seen on using Haemophilus test medium when compared to other 
Media 81. 
DETECTION OF BETA LACTAMASE ENZYME: 
    1. Phenotypic method 
    2. Genotypic method. 
Phenotypic methods: 
 Acidimetric method73: 
In this method we test the hydrolysis of the beta lactam ring and the production of   
penicilloic acid which is indicated as a colour change. To 1,000,000 units of benzylpenicillin-
5% of 0.5ml phenol red solution diluted in 4.5ml distilled water .Add a drop of 1M NaOH. 
Inoculate the bacteria. Colour change from violet colour to yellow colour within 1 minute 
indicates beta lactamase activity. 
 Iodometric method 74: 
The concept of this iodometric method is that the penicillin molecule does not bind to iodine 
directly where as if the beta lactamase activity is present, the penicillin gets reduced to 
penicilloic acid and this product is capable of binding to the iodine .so there is no chance for 
further reaction with starch and the end product is colorless. 
 Chromogenic cephalosporin method 73: 
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The beta lactamase activity can be detected by change in colour from yellow to red in one 
min by using nitrocefin dissolved in DMSO.  
 These three methods rapidly detect beta-lactamase activity in Haemophilus influenzae. 
The chromogenic cephalosporin method was easy to perform and the reagents could be stored 
for up to three weeks. The phenol red method was simple to perform but the iodometric 
method was more time consuming. All three tests gave identical results 73. 
Genotypic method:  
  Polymerase chain reaction is used to determine the TEM-1 mediated resistance. 
Primers specific for bla TEM and blaROB ampicillin resistance genes were selected and their 
specificity is checked using series of E.coli isolates with ampicillin resistant genes82. 
 Literature studies suggest that beta lactamase activity is positive in 15% overall.TEM-
1 mediated resistance is 93.7% and ROB-1 is 4.6% respectively.ROB-1 genes are more 
commonly isolated from people of North America and is more sensitive to cefaclor and 
cefprozil than TEM-1 beta lactamases83. 
 PRESERVATION AND STORAGE8, 11: 
  Haemophilus influenzae strains can be stored in chocolate agar slopes for about 4-6 
weeks. If the Trypticase soy broth or the Brain heart infusion broth supplemented with 
glycerol is used, recovery of Haemophilus is good .Supplementation of the skimmed milk 
with glucose, yeast extract and glycerol maintain the viability of Haemophilus influenzae at a 
highest rate both at -20oC AND -70OC.High survival percentage can be attained when 
thawing at room temperature does not exceed more than 3 hours. Viable cell counts were 
carried out after 0, 10, 30 and 60 days and 4, 6 and 12 months of storage to determine 
viability. Lyophilized strains can be stored for several years. 
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Hib VACCINES: 
 Vaccines are prepared against type b polyribosylribitiol phosphate capsule as it is an 
important virulence factor.  Response to this vaccine by infants less than 2 months is very 
poor. So a combination of four vaccines (PRP-diptheria toxoid conjugated vaccines (PRP-D), 
Outer membrane protein of Neisseria meningitides conjugated (PRP-OMP), Cross reacting 
mutant diphtheria protein (PRP-HbOC), Tetanus–toxoid conjugated vaccine (PRP-T) 84 was 
tried and they showed good results. Concept behind these conjugated vaccines is to increase 
their immunogenicity.  
 Epidemiology and clinical manifestations of Haemophilus influenzae infections have 
undergone dramatic changes in the last 2 decades84. The use of Haemophilus influenzae type 
b vaccines has eradicated Hib disease more widely. These vaccines induce humoral responses 
and also reduce the nasopharyngeal carriage of Hib. The vaccines had a great impact in 
reducing the incidence of the Hib disease85. 
 Studies suggest that pneumococcal vaccines also have a great impact over the 
prevention of Haemophilus influenzae85. The incidence of Haemophilus influenzae type b 
meningitis (median-21 cases per 1,00,000 population per year; range-1 to 95 cases per 
1,00,000 population per year) in Asia and central European countries is less than other areas 
where the median is 5 and 11 cases per 1,00,000 per year respectively 86 was also noted. 
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AIMS: 
 To isolate and characterize Haemophilus influenzae as pathogen from purulent 
respiratory samples over a period of 15 months. 
OBJECTIVES: 
 To isolate and characterize the Haemophilus influenza from the  
purulent respiratory samples suspected of Community acquired pneumonia. 
 To identify biotypes and serotypes of Haemophilus influenza. 
 To detect and characterize Ampicillin resistance in Haemophilus influenza by 
phenotypic and genotypic methods 
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Materials and Methods 
                  Study area: PSG Hospitals, Coimbatore 
                   Study type: Prospective, Observational study 
        Study population: All purulent respiratory samples from patients suspected of 
having pneumonia/respiratory tract infections will be subjected to Gram stain and 
those showing Bartlett’s scoring of  pus cells 10-25/LPF and pus cells ≥ 25/LPF were 
included in the study. 
                 Study period: 15 months  
             ETHICAL CONSIDERATION: 
 The study was undertaken in the Diagnostic Laboratory, Department of Microbiology, 
PSG Hospitals. Institutional Human ethical clearance was obtained. Sputum samples were 
collected from inpatients and outpatients with symptoms of respiratory infections.  
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Methodology: 
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Isolation of Haemophilus influenzae:  
                All samples as indicated above were inoculated on Chocolate agar, Fildes agar, 
Chocolate agar with antibiotics (Vancomycin, Bacitracin and Clindamycin), and Blood agar 
with Staphylococcus streak. (Composition of plating media in appendix) 
 Blood agar 14:            
          Blood agar was streaked with the sample along with Staphylococcus aureus and it was 
incubated at 370 C in the presence of 5-10% co2  in a candle extinction jar for 24 hours. They 
form low, translucent, convex, pinpoint colonies around the staphylococcus which provides 
the factor V for its growth. The size of the colony decreases as it goes away from the 
staphylococcus streak. This is the satellite phenomenon shown by Haemophilus influenza. 
  Chocolate agar11: 
      Heated blood agar or the Chocolate agar which provides both the hemin and NAD factor 
was streaked with the sample and it was incubated at 370 C in the presence of 5-10% co2  in a 
candle extinction jar for 24 hours. Haemophilus influenza shows a shiny, tiny, smooth, flat 
colony which smells like wetfur11. 
Fildes agar 6: 
     Fildes enrichment is an enzymatic digest of blood used to enhance the growth of fastidious 
organisms. The resultant digest is rich in growth factors including X and V factor required by 
Haemophilus influenzae. To the BHI chocolate agar of 100 ml, add 5ml of Fildes enrichment 
broth and allow the media to set. The sample is streaked and incubated at 370C in the 
presence of 5-10% co2  in a candle extinction jar for 24 hours. Colony morphology is very 
similar to that on chocolate agar. 
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Chocolate agar with VBC 16: 
           The CHOC-VBC media was made by preparing chocolate agar and the following 
antibiotics were added in concentrations of 5 microgram/ml Vancomycin, 300 microgram/ml 
of Bacitracin, 1 microgram/ml of clindamycin 16.After that the media is allowed to dry and 
the samples are directly streaked on to the plates and incubated at 370C in the presence of 5-
10% co2  in a candle extinction jar for 24 hours.   Haemophilus influenza shows a shiny, tiny, 
smooth, flat, slightly yellow colony which smells like wetfur11 
Identification of Hemophilus influenza:  
 Suspect colonies were those colonies which were non hemolytic, smooth, flat or low convex, 
shiny, easily emulsifiable and smelling like ‘wet fur’ 11 ‘pungent odour’ 10. 
All suspect colonies were subjected to Gram stain6 and Satellitism for initial identification. 
Gram stain characteristically shows Gram negative, small pleomorphic bacilli.  The isolate 
was confirmed as Haemophilus influenzae by a negative porphyrin test and its requirement of 
X and V factor. 
Porphyrin synthesis test 6: 
 This test indicates the absence of requirement of X factor. If &Amino levulinic acid is 
provided to the bacterium, it synthesizes it and excretes porphobilinogen and other 
porphyrins. This test is carried out by using kovac’s indole reagent (Para dimethyl amino 
benzaldehyde) and formation of pinkish red colour in the lower water phase indicates the 
synthesis of porphyrin and absence of X factor requirement. 
X and V requirement 10:  
Make a lawn culture in the Muller Hinton agar plate and keep the commercially available 
discs X and V from HIMEDIA laboratories. The X factor (hemin) and V factor (Coenzyme- 
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Nicotinamide adenine dinucleotide NAD+) are impregnated on the sterile filter paper discs of 
diameter 6 mm. If both X and V factors are required, then the organism will grow only in the 
vicinity of the X+V factor discs. 
Typing:  
1. Biotyping was done using the biochemical tests as follows Indole production, 
Ornithine decarboxylation and urease production 6 
          2. Serotyping was done using –Becton-Dickinson --- Kit as follows. 
Biotyping:  
TEST I II III IV V VI VII VIII 
INDOLE + + - - + - + - 
ORNITHINE  + - - + + + - - 
UREASE + + + + - - - - 
Indole production 6: 
 Indole production by Haemophilus influenza is detected by adding a loopful of bacteria to 
the peptone. Incubate for 24 hours at 37oC.Next day add Kovac’s reagent 5 drops. 
    Appearance of pink colour on the alcohol layer indicates indole production.  
Ornithine decarboxylation6: 
Inoculate light inoculum in to the medium and incubate at 37 o c for 18-24 hours. A control 
tube without an amino acid should be inoculated .Overlay the test and the control tubes with 
sterile paraffin oil .Under these conditions the oxygen in the medium is used up by the 
organism and this will control the pH. 
     Purple color change in the medium indicates the decarboxylation of ornithine. 
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Urease production6 
 To determine the ability of the organism to split urea, and two molecules of ammonia is 
formed by the action of the constitutive enzyme urease with resulting alkalinity. Inoculate 
heavy inoculum in to the medium and incubate at 37 o c for 18-24 hours. If the organism 
utilizes the urea, ammonia is formed  
    Appearance of pink colour indicates positive reaction. 
Serotyping: 
     As per the manufacturer’s kit (BD Difco catalogue no. Type b-222361 
                                                                                             Type a-222501 
                                                                                             Type f-227921) 
Principle:  
        Serological confirmation involves the reaction in which the microorganism (antigen) 
reacts with its corresponding antibody. This in vitro reaction produces macroscopic clumping 
called agglutination. The test is done from the 24 hours growth of the isolate in chocolate 
agar. Transfer a loopful of growth to a drop of 0.85% saline on a clean slide. Emulsify in it. 
Rotate the slide for one minute. Observe for auto agglutination. Auto agglutination if present, 
the culture cannot be tested. If auto agglutination is not seen then we can proceed with further 
steps. 
      Culture isolates are tested with Difco Haemophilus influenzae monospecific antiserum b, 
a and f. 
Steps in the procedure: 
    1. Put 1 drop of the Difco Haemophilus influenzae antiserum on a clean glass slide. 
    2. Transfer a loopful of growth to the drop of antiserum and mix thoroughly. 
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    3. Rotate the slide for 1 min and read for agglutination of 3+ or more agglutination within 
1 min. 
Antibiotic susceptibility testing:   
Antibiotic susceptibility testing was done by Kirby Bauer disc diffusion method on Chocolate 
agar 30.      .                
        In   100 mm Petri dish plates, 6 discs were kept at a distance not more than 24 mm apart. 
The isolates were tested for its susceptibility to Ampicillin, Ceftrioxzone,   Azithromycin, 
Tetracycline, Ciprofloxacin, Cotrimoxazole, and Rifampicin. Make a lawn culture on the 
chocolate agar using direct colony suspension and incubate at 37 0c for 24 hours 87 .Next day 
the zone of inhibition was measured by holding the petri plate a few inches above a black 
background illuminated with transmitted light. 
As per CLSI guidelines 2014 the sensitivity zones were noted down which is shown in the 
following table. 
DRUG SENSITIVE ZONE (>) RESISTANT ZONE 
Ampicillin 22mm 18mm 
Ceftrioxzone 26mm - 
Ciprofloxacin 21mm - 
Azithromycin 12mm - 
Tetracycline 29mm 25mm 
Cotrimoxazole 16mm 10mm 
Rifampicin 20mm 16mm 
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Detection of Ampicillin resistance  
                         1. Phenotypic method 
                         2. Genotypic method 
 
Phenotypic method: 
 Acidimetric method 88:    
                             2 mL of 0.5% aqueous phenol red solution was diluted with 16.6 mL 
distilled water and 1.2 g of benzyl penicillin was added. The pH was adjusted to 8.5 with 1 M 
NaOH. The resulting solution was violet in colour, and stored at –20°C. Before use, 100 µl 
portions were distributed into tubes or microtitre wells and inoculated with bacteria from 
culture plates (not broth) to produce dense suspensions. A yellow colour within 5 min 
indicates β-lactamase activity. Positive and negative controls must be run in parallel. This test 
can be carried out in filter paper strip method also. 
Genotypic method: 
       Molecular method PCR 
Principle: 
 Polymerase chain reaction amplifies a specific target region of the template DNA 
strand. Using suitable primers and cycling conditions the blaTEM-1 gene was amplified and 
identified. 
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Steps involved: 
 DNA extraction. 
 Amplification using Thermo cyclers 
 Agarrose gel electrophoresis 
DNA extraction: 
 Colonies of Haemophilus influenza is emulsified in to BHI broth and allowed to grow 
overnight.  
 The turbid broth is centrifuged at 5000 rpm for fifteen minutes.  
 The pellet is then transferred to small eppendorph tubes and 0.5 ml of distilled water is 
added to pellet. 
  Vortex and then centrifuge at 10,000 rpm for 5 minutes.  
 The DNA extraction is done by boiling method .Keep the above mixture in water bath 
at 95 0C for 20- 30 minutes.  
 The tubes were cooled to room temperature, centrifuged at 3000 rpm for five minutes.  
 The supernatant was used as the DNA extract. 
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Primers used for Amplification: 82 
Gene Primers primer sequence                              Base pair 
bla TEM -1 
 
Forward 
 
Reverse 
5’TGG  GTG CAC GAG TGG GTT AC 3’            
                                                                        526 
5’ TTA TCC GCC TCC ATC CAG TC 3’   
   
 For one reaction to take place 12.5 micro liters of the master mix , 5.5 micro liters of PCR 
water and 2 micro liters of the forward and reverse primers are mixed up. From that 20 micro 
liters is added up to the 5 micro liters of the DNA extract and then amplified using a thermo 
cycler. 
Amplification using thermo cycler 82: 
The blaTEM assays used the following cycle parameters in the thermo cycler: 
 94 0 C for 5 min 
 30 cycles of 94 0 C for 2min 
 57 0 C for 1 min. 
 72 0 C for 2 min followed by  
 72 0 C for 10 min. 
 4 0 C for 5 min. 
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Gel preparation: 
preparation of working buffer using millipore water: 
 Tris base ……………..10.78 gm 
 Boric acid…………….5.50 gm 
 EDTA…………………3.72 gm 
 Distilled water……………1000ml 
      pH 8.3 
 Working buffer………….1X 
          (10 times dilution of 10X is 1X-450 ml of Millipore water (nuclease free water) +50ml 
of 10X buffer) 
 Ethidium bromide …………..10mg/ml 
 
Gel preparation: 
 To 40 ml of 1X buffer,  0.35 gm of Agarose was added .It was mixed  well and kept  in 
microwave oven for 2min.After cooling for few minutes 1microlitre of ethidium bromide was 
added. Finally the mixture was poured off in to the trough with the comb and allowed to set 
for ten minutes. 
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Five microlitres of each amplicon was loaded with 3 microlitres of methylene blue dye. Test 
samples, positive and negative controls were loaded into appropriate wells.100 basepair plus 
DNA ladder, ready to use was used as the molecular ladder (Fermentas, Genetix Biotech Asia 
PVT Ltd, Bangalore). 
 Then the gel was transferred to the tank with the current passing from cathode to 
anode at 55 Volts for ten minutes and then the voltage is increased to 99 V for 45 minutes.Gel 
documentation was done under UV light  using GELDOC XR. 
Results and interpretation: 
    The isolate was considered positive for bla TEM-1 gene when a band was obtained at 
the level of the positive control band (526 bp), which was comparable to the 526 bp of the 
molecular ladder. Isolates which did not possess the gene did not produce any band. 
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Results and analysis: 
 During the study period from April 2014 to August 2015, a total of 4296 respiratory 
samples from patients suspected to have pneumonia were received in our hospital. Out of 
these in 2756 samples the pus cells per LPF was less than 10, therefore these samples were 
considered as inappropriate for culture and none yielded growth of Haemophilus influenzae. 
 Cultivation of the remaining 1540 samples (968 samples were with pus cells > 25/LPF 
and 572 samples were with pus cells 10-25/LPF), yielded Haemophilus influenzae in 103 
cases. Among the 103 isolates, 79(76.6%) were from sputum samples with pus cells > 
25/LPF and 24(23.3%) were from sputum samples with pus cells 10- 25/LPF. 
 All the Haemophilus influenzae isolates were further analyzed by Biotyping and 
Serotyping methods. The study includes patients of all age groups. 
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Age wise distribution of Haemophilus influenzae: 
 Among the Haemophilus influenzae isolates, 44.7%  of them seen in age group  61-80 
years, 27.2% from 41-60 years, 16.5% from 21-40 years, 4.8% from 11-20 years, 1.94% from 
6-10 years and  0.9% from < 5 years and  3.9% from >80 years of age. (Illustration No. 1)   
   
Illustration no.1: Age distribution of Haemophilus influenzae infections 
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Gender distribution: 
 Among the isolated strains of Haemophilus influenzae 63 (61.2%) were in male and 
40(38.8%) were in female patients. (Illustration no 2) 
 
 Illustration no.2: Gender distribution of Haemophilus influenzae infections 
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Seasonal variation: 
 In the winter months of October to January, 63 (61.1%) strains of Haemophilus 
influenzae were isolated. In summer months of March-May, 10(9.7%) isolates were 
identified. In the months of June to September, 12(11.65%) isolates were identified and 18 
(17.47%) isolates from February to May of 2015. 
    (Illustration no 3) 
 
Illustration no.3: Seasonal variation of Haemophilus influenzae infections                   
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Biotypes:  
 Haemophilus influenzae can be divided in to eight biotypes based on three 
biochemical tests Indole, Ornithine and Urease production. Out of 103 isolates, strains 
belonging to all biotypes were detected. Out of them 41.7% belong to biotype I, 7.8% to type 
II, 4.8% to type III, 1% to type IV, 1.9% to type V, 2.9% to type VI, 3.9% to type VII and 
33% to type VIII. (Illustration no 4) 
 
Illustration no.4: Biotype distribution among Haemophilus influenzae infections 
 
 
 
 
 
 
 
 
 
62 
 
Biotype /serotype distribution:  
  Among the 8 different biotypes identified 18 isolates of type b falls under 
biotype I, 9 isolates under biotype VIII. (Table no.1) 
Table no.1: Biotype distribution among various serotypes of H.influenzae isolates 
                   
Biotypes Type b Type a Type f Nontype b 
I 18 5 5 19 
II 2 1 1 2 
III 2 1 0 2 
IV 1 0 0 0 
V 2 0 0 0 
VI 3 0 0 2 
VII 1 1 0 2 
VIII 9 5 4 15 
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Serotype:  
  All the isolates of Haemophilus influenzae were serotyped with type b,type a and type 
f antisera.A total of  34(33%) were type b and the remaining  69 were non-type b Among the 
69 non type b strains,  46.6% were other serotypes, 10.7% were type a and  9.7% were type f. 
(Table no.2a) 
Table no.2a: Serotype distribution of Haemophilus influenzae infections 
 
            Serotypes Frequency Percent 
Type b 
Type a 
Type f 
Other Nontype b 
Total 
34 33 
11 10.7 
10 9.7 
48 46.6 
103 100.0 
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Serotypes in different age groups:  
  Among the age wise distribution noted, 27 of Haemophilus influenzae were 
isolated as Nontype b in 60 -80 years and 19 of type b from the same age group. Others are 
shown in the following table. (Table no. 2b) 
Table no. 2b: Serotype distribution of H.influenzae in different age groups 
 
Serotypes 
age category 
Total < 20  
years 
      21 - 40 
years 
41 - 60  
years 
61 - 80  
years 
> 80  
years 
H.influenzae  
nontypeb 
8 15 17 27 2 69 
H.influenzae  
type b 
P value (0.043)
0 2 11 19 2 34 
Total 8 17 28 46 4 103 
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Illustration no.5: Serotype distribution of H.influenzae in different age groups 
 
 
 Comparison of Haemophilus influenzae serotype b in different age groups showed that 
no cases were identified in age groups less than 20 years after the introduction of vaccine in 
our tertiary care hospital. The statistical analysis of Chi-square tests gives a P value of 0.043 
and since this value is less than 0.05, makes it as a significant study. 
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Antibiotic susceptibility of Haemophilus influenzae: 
 Antibiotic sensitivity testing of 103 isolates of Haemophilus influenzae showed that 
91.2% were sensitive to Ceftrioxzone, 96.1% to Azithromycin, 94.2% to ciprofloxacin, 
85.4% to Ampicillin, 97.08% to Tetracycline and the 65.04% Cotrimoxazole shown in Table 
No.3  
Table no.3: Antibiotic susceptibility of Haemophilus influenzae by  
                 Kirby bauer disc diffusion method 
Antibiotics 
Sensitivity Resistance 
Number percentage Number percentage 
Ceftriaxone 94 91.2% 9 8.73% 
Azithromycin 99 96.1% 4 3.90% 
ciprofloxacin 97 94.2% 6 5.90% 
Ampicillin 88 85.4% 15 14.6% 
Tetracycline 100 97.08% 3 2.91% 
cotrimoxazole 67 65.04% 36 35.00% 
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Detection of Ampicillin resistance: 
 Detection of Ampicillin resistance by Kirby-Bauer disc diffusion method: 
 Among the 103 isolates of Haemophilus influenzae isolated, 15(14.6%) strains 
showed Ampicillin resistance. (Table no 4) 
Table no.4: Ampicillin resistance among H.influenzae isolates 
H.influenzae Frequency Percent 
Ampicillin sensitive 88 85.4 
Ampicillin resistant 15 14.6 
Total 103 100 
 
   Detection of Ampicillin resistance by the phenotypic acidimetric method: 
         All the 15 (14.6%) isolates of Ampicillin resistant Haemophilus influenzae showed beta 
lactamase production.   
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   Detection of Ampicillin resistance by the genotypic method- PCR 
   Out of the 15 resistant strains of Haemophilus influenzae which showed 
positive in phenotypic acidimetric method were then subjected to detection of the plasmid 
mediated resistance gene TEM-1. Among them, 13(12.6%) showed positive for TEM-1 gene. 
(Illustration no.5) 
Illustration no.6: Molecular Characterization of Ampicillin resistant isolates   
 (n= 15) 
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Association with other diseases: 
 Among the 103 isolates of Haemophilus influenzae isolated, (3) 2.9% of cases 
were associated with Pneumococcal pneumoniae and (4) 3.88% of cases were with 
Klebsiella pneumoniae. (Table. no 5) 
Table .no 5 Association of H.influenzae with other respiratory tract infections 
 
 
 
 
 
Lower respiratory tract infections from which H.influenzae were isolated: 
 Out of 103 isolates, 84 were from inpatient samples and 19 were from 
 outpatient samples. In the 84 inpatient cases, 33% of them presented with history of 
 respiratory tract infections and were diagnosed as the cases of pyrexia of unknown 
 origin, 26.2% associated with history of Bronchial asthma,18.44% associated with 
 COPD, 2.9% associated with sinusitis and 0.9% associated with Otitis media. 
(Table no.6) 
 
 
 
 
 
 
Diseases  
Tuberculosis 0 
Pneumococcal pneumoniae 3 
Klebsiella pneumoniae 4 
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Table no.6: Lower respiratory tract infections from which H.influenzae were 
                 isolated among inpatients 
            (n=84) 
PUO 34 
COPD 27 
Bronchial asthma 19 
Sinusitis 3 
Otitis media 1 
Meningitis 0 
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Figure – 1 Gram stain showing pleomorphic Gram negative bacilli 
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Figure – 2 Blood agar showing Satellitism 
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Figure – 3 Chocolate agar showing tiny colonies of H.influenzae 
 
 
 
 
 
 
 
 
 
 
Figure – 4 FILDES agar showing tiny colonies of H.influenzae 
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FIGURE- 6-Porphyrin synthesis test 
Positive test-pink colour in water phase 
 
 
 
 
 
 
 
 
 
 
 
Negativetest-nocolour  
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 Figure – 8 Seroagglutination with type b, a and f antiserum of H.influenzae 
78 
 
 Figure – 9 Ampicillin sensitive and resistant strains 
                                 
 
 
 
 
 
                           
 
   Ampicillin sensitive (Zone size = 30mm) 
 
 
 
 
 
 
                             
 
   Ampicillin resistant (Zone size=17mm) 
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Figure – 10 Phenotypic – Acidimetric method  
 
PC-(POSITIVE CONTROL)-Yellow 
NC-(NEGATIVECONTROL)-Pink
80 
 
 
 
 
 
 
 
 
 
81 
 
Figure-13 Preservation and storage by Lyophilisation 
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Discussion 
 Haemophilus influenzae causes a variety of community acquired respiratory 
infections, including sinusitis, acute otitis media, bronchitis and pneumonia. In olden days, 
these infections were mainly caused by Haemophilus influenzae serotype b (Hib).  
 In this study, majority of the cases (33%) presented with history of respiratory tract 
symptoms, 18% were associated with COPD, 2% associated with sinusitis and 0.9% 
associated with Otitis media. In the Urwin et al study, 63% of cases presented with history of 
respiratory infections and 33% presented with COPD69. 
 In this study out of 103 isolates, 95 % were seen in adults, where as others report a 
range of 72-74% in their studies done during the period of 1996-200489, 69, 96.  Still earlier 
studies done during the period from 1993-1997, show a high rate (86%) of isolation of Hib 
amongst children below 5 years of age90. A Costa Rican study have reported  a significant 
decline in the incidence of type  b H.influenzae when the data from 1992 -1997 was 
compared with that between 1999 and 2004 91. By June 2011, Hib vaccine was included in 
the National Immunization program of 170 countries in all regions of the world. After that the 
incidence of Hib invasive disease and oropharyngeal carriage in young children has 
drastically decreased wherever vaccination programs have been implemented 89, 96, 97, 98.  
 The H.influenzae isolates in this study were more commonly seen among male 
patients (61%), which is similar to other studies9,69.  In contrast, a study reports higher 
prevalence among female elderly patients, whereas a lower prevalence in female children2.  
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 In this study the isolation of H.influenzae was more (61%) during the winter months 
which are similar to other studies 6,103. In another study, an increase in the frequency of 
isolation of H.influenzae (68%) isolates was noted in rainy season when compared to that 
(32%) in the dry season91, 99, 103.  Serotyping of the isolates showed that the isolation of H 
influenzae type b has become very meager in many studies, ranging from 1-3%, but in our 
study 33% belonged to this serotype102. 
 Table no.1: Comparison of H.influenzae isolation in this study with other studies 
 
 
 
  
 
 
Study 
name/period 
Type b Non type b Type f Type a Type e 
This study 
33% 67% 10% 11% 
- 
 
Jessica R. etal101 
(1989) 
80% 17% - - - 
Amita Jain 
etal68 (2006) 
31% 68% - - - 
Jessica R. etal101 
(2008) 
3% 97% 18% 2% 6% 
Puig, Carmen 
102(2008-2013) 
1% 99% 13% -  
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 Haemophilus influenzae are divided in to eight biotypes based on the three 
biochemical tests, namely, Indole, Ornithine and Urease production.  In my study, Out of the 
103 Haemophilus influenzae isolates, strains belonging to all biotypes were detected. Out of 
them most of the isolates (44%) belonged to biotype I. There is no concurrence among the 
various studies on the biotype isolated, where in the predominant biotype varies. 
Table no.2: Comparison of biotype distribution of H.influenzae with other studies  
 
Study name Predominant 
biotype 
Percentage Year  
Our study  I 44% 2013 
Amita etal68 III 25% 2006 
Landgraf etal92 
I 70.9% 1993 
J.Wallace etal100 IV 38% 1983 
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 In this study, among the 103 isolates of Haemophilus influenzae, majority of them 
showed sensitivity to Tetracycline (97%), Azithromycin (96%), Ciprofloxacin (94%), 
Ceftrioxzone (91%) followed by Ampicillin (85%) and Cotrimoxazole (65%).The sensitivity 
to tetracycline had increased from 54% in the year 2000 to 94.5% in 2012 which is similar to 
this study.103 
   Haemophilus influenza infections showed a good response to usage of third 
generation cephalosporin especially Ceftrioxzone (91%)   and it correlates well with studies 
done from 2005 to 2007 in the United States.103, 105 In developed countries, the resistance to 
cephalosporins is very low and it varies from 0.1% to 0.3% percent which correlates with this 
study as well.111     
 Haemophilus influenzae non type b is an emerging pathogen commonly causing 
respiratory infections in adults particularly sinusitis, otitis media. These are now frequently 
treated with fluoroquinolones and their sensitivity has increased to 99% in studies done from 
2000-2013106. Our study also showed a 94% susceptibility to Ciprofloxacin.  A global study 
(SENTRY) performed by American and European institutions found that 0.15% of H. 
influenzae isolates were resistant to Fluoroquinolones 107.  
 Generally, Gram positive bacteria are more susceptible to macrolides, but H influenzae 
among many of the Gram negative bacteria also show a high susceptibility to macrolides like 
Azithromycin. In our study 99% were susceptible to Azithromycin, which was similar to 
other studies.108   High level resistance to macrolides in H.influenzae (0.5%-2%) is rare as is 
reported in many studies. 108,109,110 
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 There was no difference in susceptibility between type b and non-type b isolates to 
Ceftrioxzone, tetracycline,azithromycin and Ciprofloxacin except with Ampicillin  and 
Cotrimoxazole  in which type b isolates shows higher resistance( 26% and 47%) when 
compared to nontype b isolates .111,103 
 In my study out of the 103 isolates of Haemophilus influenzae, 35% of H.influenzae 
isolates showed resistance to Cotrimoxazole which is similar to the study done by Maestro 
etal in rural (13%) and urban children (46%) suffering from ARI infections 112 and in 
V.L.Nag etal study reporting 33% resistance. 111  
 Beta lactamase mediated resistance is seen in  15%  isolates in this study, whereas in 
multicentre studies done in US between 1984-1999 it  was 15% to 36% 111 and in recent   
studies done in China, the percentage of Ampicillin sensitive strains were progressively 
decreased from 96% in the year 2000 to 61% in 2012.103  The resistance detected was higher 
among type b (60%)strains when compared to non type b strains(40%) which is similar to 
study by V.L.Nag et al (30% and 20%) suggesting  the strains that are invasive  shows high 
Ampicillin resistance.111  
 All the resistant isolates (15) produced beta-lactamase enzyme when screened by the 
phenotypic acidimetric method, but when analyzed by molecular method, only 13 isolates 
(86%) were positive for TEM-1 gene. Beta lactamase production may also be due to presence 
of ROB-1 gene.  Whereas in another study 11% showed Ampicillin resistance, in which 73% 
were beta-lactamase positive and carried TEM-1 gene and none were positive for ROB-1 
gene 104. Many studies have shown that the isolation of TEM-1 gene (93%) is more when 
compared to the ROB-1gene isolated (5%) 83, 95. 
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Summary & Conclusion 
 
 During the study period from April 2014 - August 2015, 1540 purulent respiratory 
samples from patients with suspected pneumonia were processed.  
 Out of 1540 samples, Haemophilus influenzae was isolated in 103 samples.  
 Majority of the isolates (49%) were from the elderly, of more than 60 years of age. 
 Incidence of Haemophilus influenzae was higher in males (60%). 
 The isolation of Haemophilus influenza was more (61%) during the winter months of 
October to January.  
 Majority of Haemophilus influenzae belonged to biotype I (42%) 
 Among the isolates, type b serotype (33%) was less when compared to non type b 
serotypes (67%). 
 Type b serotype isolates were more among the age group of 60-80 years and none 
was seen in less than 5 years of age. 
 Haemophilus influenza showed high sensitivity to Tetracycline (97%), Azithromycin 
(96%), ciprofloxacin (94%), Ceftrioxzone (91%) when compared to Ampicillin 
(85%) and the Cotrimoxazole (65%).   
 There is no difference in the susceptibility to drugs between type b and Non type b 
isolates. 
 Beta lactamase H.influenzae (15%) was detected by the phenotypic acidimetric 
method. Out of them, 86% showed TEM-1 beta lactamase gene by molecular method 
PCR. 
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Appendix: 
Blood agar: 
 Sterile defibrinated sheep blood  7ml 
 Nutrient agar (melted)   100ml 
   Add sterile defibrinated sheep blood to the melted nutrient agar at 45 to 50 0 C.Pour 20 ml 
in to each Petri dish about 4mm depth. 
Chocolate agar (CA): 
CA is heated blood agar. 
 Sterile defibrinated blood   7ml 
 Nutrient agar     100ml 
Melt the nutrient agar .When the temperature is about 45-50 o C add the blood and mix well. 
After adding the blood, heat it in a water bath slowly bringing up the temperature to 75o c 
with constant agitation. Special care should be taken to avoid fluctuation in the temperature. 
 
CHOC-VBC: 
Chocolate agar is prepared as such above and the following antibiotics are added in the 
concentrations of: 
 Vancomycin…..5 microgram/ml 
 Bacitracin……300 microgram/ml 
 Clindamycin….1 microgram/ml 
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Fildes agar: 
We have to prepare BHI chocolate agar and to that 5% Fildes enrichment broth 
(commercially available from HIMEDIA) is added on to it. 
 BHI agar….3.75 gm 
 Distilled water …100ml 
Autoclave after adjusting pH to 7.4 
 Fildes enrichment broth…5ml 
 Distilled water…             100ml 
Autoclave after adjusting pH to 7.4 
Cool the media to 45 to 500 c. 
Add 5ml of sheep blood and then heat the media to 80-850c and make it to chocolate agar. 
Then add 5ml of Fildes enrichment broth to it and allow the media to set. 
Biotyping: 
  Indole test:       
                 Reagent: 
 P-Dimethylaminmobenzaldehyde       10g 
 Amyl or isoamylalcohol                   150ml 
 Concentrated HCL                            50ml 
                Medium:  
 Peptone                                                  20g 
 Sodium chloride                                      5g 
 Distilled water                                        1litre 
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           Adjust the Ph to 7.4.Dispense and sterilize by autoclaving at 121 0c at 15 minutes. 
             Method: 
                Inoculate the bacterial colonies in to the above medium aseptically and incubate at 
37 0 c for 18-24 hours. Next day add the kovac’s reagent approximately 0.5ml (5 drops) along 
the sides of the tube. 
INFERENCE: 
       The pink color seen in the water layer is considered positive. Sometimes a period of 96 
hours is required for optimum accumulation of indole. 
 Positive control: E.coli                                
 Negative control: Klebsiella 
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Urease test: 
    Principle: 
           To determine the ability of the organism to split urea in to two molecules of ammonia 
by the action of the enzyme urease with resulting alkalinity. 
  Medium: 
     Christensen’s medium: 
 Peptone    1g 
 Sodium chloride   5g 
 Monopotassium phosphate  2g 
 Glucose     1g 
 Urea     20g 
 Phenol red    0.012g 
 Agar     15g 
 Distill water    1litre 
           pH indicator : phenol red .  
Maintain pH 6.8.Then autoclave at 121 0 c at 15 minutes and then allow it to cool at 45-50 0 
c.Pour the media with a slant and butt. 
  Method: 
     Inoculate heavy inoculum in to the medium and incubate at 37 o c for 18-24 hours. If the 
organism utilizes the urea, ammonia is formed and the medium results in alkalinity. 
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Inference:  
Appearance of pink colour indicates the presence of urease enzyme 
 Positive control: Proteus spp     
 Negative control: E.coli 
Ornithine 6: 
   Principle: 
             To measure the enzymatic ability of an organism to decarboxylate an amino acid to 
form an amine with resulting alkalinity. 
   Medium: 
       Moller’s decarboxylase media: 
 Peptone     5g 
 Beef extract    5g 
 Bromocresol purple   0.1g 
 Cresol red    0.005g 
  Pyridoxal    5mg 
 Glucose      0.5g 
  l-ornithine dihydrochloride  10g 
  Distilled water   1litre. 
   Maintain     Ph. 6 . 
 Autoclave at 121 0 c at 15 minutes. 
  Cool at 45-50 0 c 
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 Method: 
           Inoculate light inoculum in to the medium and incubate at 37 o c for 18-24 hours. A 
control tube without an amino acid should be inoculated .Overlay the test and the control 
tubes with sterile paraffin oil .Under these conditions the oxygen in the medium is used up by 
the organism and this will control the pH. 
  Inference: 
                 Purple color change in the medium indicates the decarboxylation of ornithine. 
 Positive control: Enterobacter cloacae 
 Negative control: E.coli 
Porphyrin synthesis test: 
 This test indicates the absence of requirement of X factor. If &-Amino levulinic acid is 
provided to the bacterium, it synthesizes it and excretes porphobilinogen and other 
porphyrins. This test is carried out by using kovac’s indole reagent (para dimethyl amino 
benzaldehyde) and formation of pinkish red colur in the lower water phase indicates the 
synthesis of porphyrin and absence of X factor requirement. 
 Positive control: Staphlococcus aureus 87 
 Negative control:Haemophilus influenzae ATCC 49247 
 Substrate used: 
 &ALA -2mmol/lit 
 Mgso4    - 0.8 mmol/lit 
 Sodium phosphate buffer 0.1mmol/lit 
pH 6.9  
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 Distribute 0.5 ml volumes of the substrate in small tubes 
Add large loopful of bacteria from the plate 
 Incubate for 4 hours.Add 0.5ml of Kovac’s indole reagent (para dimethyl amino 
benzaldehyde) 
 Vortex and allow the phases to separate. 
 Reddish pink colour in the lower water phase indicates the synthesis of porphyrin and 
absence of X factor requirement. 
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Abstract
Introduction: 
Haemophilus influenza is strictly a human pathogen responsible for many diseases like 
community acquired pneumonia, meningitis, sinusitis, epiglottitis and otitis media. 
Haemophilus type b is the most common strain responsible for all the infections. Non 
type able strains are at emerging risk. Ampicillin resistance is being reported and is due 
to production of betalactamases. Ampicillin resistance is being reported and is  due to 
production of betalactamase, but rarely can also be due to aminoacid substitutions in the 
Penicillin binding proteins (PBP) which is known as BLNAR 
AIM: 
  To isolate and characterize Haemophilus influenzae as pathogen from purulent 
respiratory samples over a period of 15 months. 
Materials and Methods:   
All purulent respiratory samples were processed for isolation of Haemophilus influenzae. 
They were identified as H. influenzae based on its X&V factor requirement and 
Porphyrin synthesis test.  Serotyping of the isolates was done using ‘b’, ‘a’ and ‘f’ typing 
sera. Antibiotic susceptibility testing was done with reference to detection of Ampicillin 
resistance. Ampicillin resistance was characterized by phenotypic and genotypic 
methods. PCR was done for detection of TEM -1 which codes for betalactamases 
enzyme. 
 
 
 
Results: 
Out of 103 Haemophilus influenzae isolates, majority of them were isolated from elderly 
male patients (49%) and show higher incidence during the winter months .Due to the 
vaccination available against type b Haemophilus influenzae, Non type b Haemophilus 
influenzae shows higher risk (67%) when compared to type b (33%).  None of the cases 
of type b is seen in children below 5 years of age. Haemophilus influenzae shows higher 
sensitivity pattern to ceftriaxone (91%),Azithromycin  (96%)and Tetracycline (97%). 
There is no difference in the susceptibility to drugs between type b and Non type b 
isolates. Beta lactamase positive H. influenzae were seen in 15 isolates .Out of them, 13 
showed TEM-1 beta lactamase gene by PCR. 
KEYWORDS: satellitism, XV factor requirement, Porphyrin synthesis test, Fildes 
agar,TEM-1 
  
 
